GO
Loading...

Urban Outfitters Inc

More

  • *Starboard Value takes stakes in Office Depot, Staples. Retailers were among the day's biggest percentage gainers on the S&P 500, including Urban Outfitters, up 7.6 percent at $32.29. "It suggests overall spending is going to do well," said Peter Cardillo, chief market economist at Rockwell Global Capital in New York.

  • *Starboard Value takes stakes in Office Depot, Staples. Retailers were among the day's biggest percentage gainers on the S&P 500, including Urban Outfitters, up 7.6 percent at $32.29. "It suggests overall spending is going to do well," said Peter Cardillo, chief market economist at Rockwell Global Capital in New York.

  • *Starboard Value takes stakes in Office Depot, Staples. NEW YORK, Dec 11- U.S. stocks bounced back on Thursday, with the S&P 500 surging more than 1 percent, as data pointed to a strengthening U.S. economy and boosted optimism about holiday spending. "It suggests overall spending is going to do well, and today's rally confirms the resumption of a year-end rally which...

  • *Starboard Value takes stakes in Office Depot, Staples. NEW YORK, Dec 11- U.S. stocks bounced back on Thursday, with all three major indexes surging more than 1 percent, as data pointed to a strengthening U.S. economy and boosted optimism about holiday spending. "It suggests overall spending is going to do well, and today's rally confirms the resumption of a year-end...

  • Cramer basics: Don't invest without these 3 things Friday, 28 Nov 2014 | 1:12 PM ET

    Jim Cramer reveals three things that must be in place before you even think about investing.

  • Cramer: Should we fear the fear index? Tuesday, 25 Nov 2014 | 6:26 PM ET

    Jim Cramer goes off the charts with technician Mark Sebastian to find out why the CBOE VIX is high, and if investors should be concerned.

  • Cramer: Adios, Fed rally market! Tuesday, 25 Nov 2014 | 6:14 PM ET
    2014 Ford F-150 trucks are prepared to come off the assembly line at the Ford Dearborn Truck Plant June 13, 2014, in Dearborn, Michigan.

    Hallelujah! The market has finally rallied off of something besides the Fed. Jim Cramer dives into what is stirring up good news.

  • Dow, S&P end near records; GDP better than thought Tuesday, 25 Nov 2014 | 4:51 PM ET

    Stocks rose Tuesday after data had the U.S. economy growing more than forecast in the third quarter.

  • Cramer Remix: This industry isn't dead yet! Monday, 24 Nov 2014 | 7:08 PM ET

    A big positive sign in this once left-for-dead sector has turned Cramer's attention to a handful of stocks that could go higher.

  • Cramer speculates: Is the mall really dead? Monday, 24 Nov 2014 | 6:40 PM ET
    Pedestrians carrying shopping bags walk past a Victoria's Secret store in New York.

    Will Black Friday even make a dent at the mall this year? Jim Cramer has a stock up his sleeve that could run ahead of the rest of them.

  • Cramer: Check your attitude at the door, Dan Loeb Monday, 24 Nov 2014 | 6:22 PM ET
    Daniel Loeb

    Jim Cramer is disgusted with the tactics taken by this hedge fund activist.

  • Cramer's recipe for high prices in 2015 Monday, 24 Nov 2014 | 6:10 PM ET
    The Apple flagship store on 5th Avenue in New York.

    Money managers are looking for a reason to buy right now, and Jim Cramer is here to help. He goes sector by sector to offer his pick of hot stocks.

  • Nasdaq rallies; Dow, S&P 500 close at record highs Monday, 24 Nov 2014 | 4:49 PM ET
    A trader works on the floor of the New York Stock Exchange.

    Stocks rose on Monday as investors drew cheer from central-bank action to boost the global economy and M&A.

  • Cramer: Retail stocks run amok Tuesday, 18 Nov 2014 | 6:40 PM ET

    Retail rut or retail rally? Jim Cramer gives his take on recent headwinds in retail. It all comes down to execution...

  • Actavis Plc, Gilead Sciences and other biotechs were among the biggest drivers, a day after Allergan agreed to be bought by Actavis. Shares of Actavis were up 8.7 percent at $269.60, helped by bullish analyst notes, while Gilead's stock rose 3.3 percent to $103.71 percent. "A little bit of a risk trade is coming back on, and those are the areas for the M&A," said Uri...

  • Actavis Plc, Gilead Sciences, Celgene and other biotech names were among the S&P 500' s biggest drivers, a day after Allergan agreed to be bought by Actavis. The S&P health care index was up 1.6 percent, while shares of Actavis were up 8.3 percent, Gilead's rose 3.3 percent and shares of Celgene were up 2.4 percent. Helping Actavis were bullish analyst notes.

  • US STOCKS-S&P 500 hits record, healthcare leads gains Tuesday, 18 Nov 2014 | 1:45 PM ET

    Actavis Plc, Gilead, Celgene and other biotech names were among the S&P 500' s biggest drivers, a day after Allergan agreed to be bought by Actavis. The S&P health care index was up 1.4 percent, while shares of Actavis were up 7.7 percent, Gilead's rose 2.9 percent and shares of Celgene were up 2.4 percent. Helping Actavis were bullish analyst notes.

  • US STOCKS-S&P 500 hits record again; Actavis rallies Tuesday, 18 Nov 2014 | 11:01 AM ET

    NEW YORK, Nov 18- U.S. stocks rose on Tuesday, lifting the S&P 500 to a record high, boosted by healthcare after Actavis' acquisition of Allergan triggered bullish analyst notes. Allergan on Monday accepted a $66 billion takeover bid from Actavis Plc in cash and stock. At least two analysts raised Actavis' price target, one to as high as $300.

  • The IPO rush begins Tuesday, 18 Nov 2014 | 10:06 AM ET
    Traders work the floor of the New York Stock Exchange.

    The IPO rush begins! There are 12 deals that are set to price this week. This is the rush to get deals done before Thanksgiving!

  • Early Movers: HD, MDT, EA, ZTS, GPRO, IBM & more Tuesday, 18 Nov 2014 | 9:01 AM ET

    Some of the names on the move ahead of the open.